When are the treatment sessions and how much time will they take?
The study lasts about 6 weeks with a visit about once a week. Then there are two follow-up visits 1 month and 3 months after the end of the study.
Where do the study visits occur?
All study visits occur at Boston University’s Center for Anxiety and Related Disorder at 648 Beacon St, Boston, MA. We are located right next to the Kenmore T stop for easy access by public transportation.
Will I be compensated for my participation?
Eligible participants may receive up to $120 for participating in a variety of study visits. The CBT (therapy) will not provide compensation. This study is not suited for people who are primarily interested in compensation. This study is for people who have difficulties with worry and anxiety and are interested in getting treatment for those problems.
Is this individual or group treatment?
All treatment is done in a group format. Each group will consist of 4-6 adult participants who are going through similar difficulties with social anxiety and managing worry. You will receive periodic evaluations throughout the study that will be conducted individually with one of the study clinicians.
Will I be able to choose which treatment I receive?
No, you will be randomly assigned to one of the treatment conditions. However, you will receive regular evaluations of your progress regardless of your treatment condition.
How do I know if I am eligible for the study?
The best way to find out whether this study is a good fit for you is to call us at 617-358-2250. We will ask you some preliminary questions about your symptoms of anxiety and worry, and may schedule a more in-depth assessment at our clinic if it seems like the study may be a good fit.
What are possible risk associated with the study?
The routine medical and laboratory test will evaluate the safety of the procedures, your medication use, and drug allergies. During the fear extinction part of the study, the electric shocks you receive will be uncomfortable, but not painful or dangerous. There are no known or foreseeable risks associated with the study procedures. There are no expected risks associated with the interviews or psychological tests other than possible discomfort involved in answering some of the questions. The CBT (therapy) offered may make some individuals anxious during the social exposure procedures, but your therapist will work with you to make the exposure sessions during CBT tolerable. D-cycloserine has been used in previous studies with individuals with various anxiety disorders. Mild side effects are most commonly related with doses greater than 500mg/day, which is ten times the amount that you may receive in this study.